FAQ: Domande frequenti
Che cos'è la PSSD?
Chi riguarda?
Quali sono i sintomi sessuali?
Quali sono i sintomi non sessuali?
Quali sono le modalità di insorgenza?
Come posso sapere se soffro di PSSD?
Cosa può suggerire che non è PSSD?
Risposta alla domanda selezionata

Transcriptomic Profile of the Male Rat Hypothalamus and Nucleus Accumbens After Paroxetine Treatment and Withdrawal: Possible Causes of Sexual Dysfunction (2024)


Molecular Neurobiology https://doi.org/10.1007/s12035-024-04592-9

Transcriptomic Profile of the Male Rat Hypothalamus and Nucleus Accumbens After Paroxetine Treatment and Withdrawal: Possible Causes of Sexual Dysfunction

Published: 04 November 2024

Silvia Giatti, Lucia Cioffi, Silvia Diviccaro, Gabriela Chrostek, Rocco Piazza & Roberto Cosimo Melcangi

Abstract

Paroxetine, a selective serotonin reuptake inhibitor (SSRI), may induce sexual dysfunction during treatment and upon discontinuation. The mechanisms involved have been poorly explored so far. We have analyzed, by RNA sequencing, the whole transcriptomic profile in the hypothalamus and nucleus accumbens (NAc) (two brain regions involved in sexual behavior) of male rats daily treated for 2 weeks with paroxetine (T0) and at 1 month of withdrawal (T1). Data here reported show seven differentially expressed genes (DEGs) at T0 and 1 at T1 in the hypothalamus and 245 at T0 and 6 at T1 in the NAc. In addition, Gene-Set Enrichment, Gene Ontology, and Reactome analyses confirm that inflammatory signature and immune system activation were present at T0 in both brain areas. Considering that inflammation is generally associated with depression and that no paradigms inducing the pathology were here applied, these SSRI pro-depressive effects should be considered in patients without a clear indication of depression. Moreover, DEGs related to neurotransmitters with a role in sexual behavior and the reward system, such as dopamine (e.g., sialyltransferase 8B—ST8SIA3), glutamate (e.g., glutamate receptor ionotropic delta-2—GRID2) and GABA (e.g., glutamate decarboxylase type 2—GAD2) or associated with neurexin and neuroligin pathways and brain-derived neurotrophic factor (BDNF) signaling, were reported to be dysregulated in the NAc, further confirming dysfunction in this brain area. Interestingly, the analysis of DEGs altered at T1 in the NAc confirms the persistence of some of these side effects providing further information for post-SSRI sexual dysfunction (PSSD) etiopathogenesis.

Keywords SSRI · Antidepressant · PSSD · RNA sequencing · Side effects